ConductScience.org, home

Paper207382

Clinical use of 1-alpha-hydroxyvitamin D3.

Br Med J, 1978. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. Clinical use of 1-alpha-hydroxyvitamin D3. Papers, record 207382. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/207382

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Clinical use of 1-alpha-hydroxyvitamin D3.
PubMed
Journal
Br Med J
PubMed
Year
1978
PubMed
Publication types
Editorial
PubMed
Citations, by iCite
1
iCite
Relative citation ratio, by iCite
0.02
iCite
Revised in PubMed
2019-05-01
PubMed

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
HydroxycholecalciferolsMajor topic
Bone Diseases
Cholecalciferol
Dihydroxycholecalciferols
Humans

References12

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1606428Bone disease and hyperparathyroidism in chronic renal failure: the effect of 1alpha-hydroxyvitamin D3.Clin Endocrinol (Oxf)1977https://conductscience.org/library/papers/606428PubMed
2203417Long-term therapy with 1alpha-hydroxyvitamin D3 in children with 'pseudo-deficiency' rickets.Clin Endocrinol (Oxf)1977https://conductscience.org/library/papers/203417PubMed
3187056Familial forms of vitamin D-resistant rickets revisited. X-linked hypophosphatemia and autosomal recessive vitamin D dependency.Am J Clin Nutr1976https://conductscience.org/library/papers/187056PubMed
4342145Physiological and therapeutic differences between vitamin D, its metabolites and analogues.Clin Endocrinol (Oxf)1977https://conductscience.org/library/papers/342145PubMed
5333287Basic and clinical concepts related to vitamin D metabolism and action (first of two parts).N Engl J Med1977https://conductscience.org/library/papers/333287PubMed
61196134Effects of 1alpha-hydroxy-vitamin D3 and 1,25-dihydroxy-vitamin D3 on calcium and phosphorus metabolism in hypoparathyroidism.Metabolism1975https://conductscience.org/library/papers/1196134PubMed
7606414The effect of 1alpha-hydroxyvitamin D3 with and without oestrogens on calcium balance in post-menopausal women.Clin Endocrinol (Oxf)1977https://conductscience.org/library/papers/606414PubMed
8832019Rate of reversal of hypercalcaemia and hypercalciuria induced by vitamin D and its 1alpha-hydroxylated derivatives.Br Med J1977https://conductscience.org/library/papers/832019PubMed
957505Variable response to long-term 1alpha-hydroxycholecalciferol in haemodialysis osteodystrophy.Lancet1976https://conductscience.org/library/papers/57505PubMed
104365934Metabolism and action of the hormone vitamin D. Its relation to diseases of calcium homeostasis.West J Med1974https://conductscience.org/library/papers/4365934PubMed
11932193Comparison of effects of 1 alpha-hydroxy-vitamin D3 and 1,25-dihydroxy-vitamin D3 in man.J Clin Invest1976https://conductscience.org/library/papers/932193PubMed
126064191alpha-hydroxyvitamin D3 in primary hyperparathyroidism.Clin Endocrinol (Oxf)1977https://conductscience.org/library/papers/606419PubMed

Download CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Authors
  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/207382

GET https://conductscience.org/api/papers/v1/207382/authors